Department of Surgery, Section of Endocrine Surgery, H4/750 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA.
World J Surg. 2012 Mar;36(3):607-11. doi: 10.1007/s00268-011-1394-y.
Prior head and neck irradiation is a known risk factor for hyperparathyroidism. It is not clear whether irradiation for breast cancer, which may expose the neck to radiation, is also a risk factor for hyperparathyroidism. The present study analyzes the association between the side of radiation to the chest following breast surgery and the side of subsequent parathyroid adenoma development.
We analyzed a prospective database of 1,428 consecutive patients who underwent parathyroidectomy at our institution between November 2000 and August 2010. Patients who had previously undergone breast surgery were identified. Patients with multigland disease were excluded. Patients with bilateral breast surgery were counted as having had two separate procedures; one on each side. Patients who had radiation therapy following breast surgery (RadRx) were compared to those who had breast surgery without radiation treatment (No RadRx).
A total of 146 breast procedures were performed in 121 patients. Forty procedures were in the RadRx group versus 106 cases in the No RadRx group. Patients with radiation therapy were older (68 ± 1.8 years versus 63 ± 1.2 years; P = 0.02) and had higher preoperative calcium levels (11.3 ± 0.1 mg/dl versus 10.9 ± 0.1 mg/dl; P = 0.001). However, there was no significant difference in either parathyroid hormone (PTH) level or gland weight. The latency period between breast irradiation and parathyroid surgery was 8 ± 0.9 years. Interestingly, the side of radiation therapy was associated with the side of the parathyroid adenoma in 76% of cases, compared to only 44% in those who had breast surgery without radiation exposure (P = 0.0004).
The present study demonstrates that, similar to prior head and neck radiation, prior breast irradiation correlates with the development of parathyroid disease. Specifically, there is a strong correlation between the side of the radiation therapy and the side of a subsequent parathyroid adenoma. Breast irradiation should therefore be considered a risk factor for the development of parathyroid adenomas.
先前的头颈部放疗是甲状旁腺功能亢进的已知危险因素。目前尚不清楚乳腺癌放疗是否也是甲状旁腺功能亢进的危险因素,乳腺癌放疗可能会使颈部暴露于辐射之中。本研究分析了乳腺癌手术后胸部照射的侧别与随后甲状旁腺瘤发展的侧别之间的关系。
我们分析了 2000 年 11 月至 2010 年 8 月期间在我们机构接受甲状旁腺切除术的 1428 例连续患者的前瞻性数据库。确定了先前接受过乳房手术的患者。排除了多腺体疾病患者。双侧乳房手术的患者被算作进行了两次单独的手术,一次在一侧。将接受过乳房手术后放疗(RadRx)的患者与未接受过乳房手术后放疗(No RadRx)的患者进行比较。
在 121 例患者中进行了 146 例乳房手术。RadRx 组有 40 例手术,No RadRx 组有 106 例手术。接受放疗的患者年龄较大(68 ± 1.8 岁 vs. 63 ± 1.2 岁;P = 0.02),术前血钙水平较高(11.3 ± 0.1 mg/dl vs. 10.9 ± 0.1 mg/dl;P = 0.001)。然而,甲状旁腺激素(PTH)水平或腺体重量均无显著差异。乳房放疗与甲状旁腺手术之间的潜伏期为 8 ± 0.9 年。有趣的是,在 76%的病例中,放疗侧与甲状旁腺瘤的侧别相关,而在未接受放疗的乳房手术患者中,这一比例仅为 44%(P = 0.0004)。
本研究表明,与先前的头颈部放疗类似,先前的乳房放疗与甲状旁腺疾病的发生相关。具体而言,放疗侧与随后甲状旁腺瘤的侧别之间存在很强的相关性。因此,乳腺癌放疗应被视为甲状旁腺瘤发生的危险因素。